Plasma membrane transporters of serotonin, dopamine, and norepinephrine mediate serotonin accumulation in atypical locations in the developing brain of monoamine oxidase A knock-outs

Détails

Ressource 1Télécharger: 6914.full.pdf (1082.26 [Ko])
Etat: Public
Version: Final published version
ID Serval
serval:BIB_AB1ABFD40F4E
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Titre
Plasma membrane transporters of serotonin, dopamine, and norepinephrine mediate serotonin accumulation in atypical locations in the developing brain of monoamine oxidase A knock-outs
Périodique
Journal of Neuroscience
Auteur⸱e⸱s
Cases  O., Lebrand  C., Giros  B., Vitalis  T., De Maeyer  E., Caron  M. G., Price  D. J., Gaspar  P., Seif  I.
ISSN
0270-6474 (Print)
Statut éditorial
Publié
Date de publication
09/1998
Volume
18
Numéro
17
Pages
6914-27
Notes
Journal Article
Research Support, Non-U.S. Gov't --- Old month value: Sep 1
Résumé
Genetic loss or pharmacological inhibition of monoamine oxidase A (MAOA) in mice leads to a large increase in whole-brain levels of serotonin (5-HT). Excess 5-HT in mouse neonates prevents the normal barrel-like clustering of thalamic axons in the somatosensory cortex. Projection fields of other neuron populations may develop abnormally. In the present study, we have analyzed the localization of 5-HT immunolabeling in the developing brain of MAOA knock-out mice. We show numerous atypical locations of 5-HT during embryonic and postnatal development. Catecholaminergic cells of the substantia nigra, ventral tegmental area, hypothalamus, and locus ceruleus display transient 5-HT immunoreactivity. Pharmacological treatments inhibiting specific monoamine plasma membrane transporters and genetic crosses with mice lacking the dopamine plasma membrane transporter show that the accumulation of 5-HT in these catecholaminergic cells is attributable to 5-HT uptake via the dopamine or the norepinephrine plasma membrane transporter. In the telencephalon, transient 5-HT immunolabeling is observed in neurons in the CA1 and CA3 fields of the hippocampus, the central amygdala, the indusium griseum, and the deep layers of the anterior cingulate and retrosplenial cortices. In the diencephalon, primary sensory nuclei, as well as the mediodorsal, centrolateral, oval paracentral, submedial, posterior, and lateral posterior thalamic nuclei, are transiently 5-HT immunolabeled. The cortical projections of these thalamic nuclei are also labeled. In the brainstem, neurons in the lateral superior olivary nucleus and the anteroventral cochlear nucleus are transiently 5-HT immunolabeled. None of these structures appear to express the monoamine biosynthetic enzyme L-aromatic amino acid decarboxylase. The administration of monoamine plasma membrane transporter inhibitors indicates that the 5-HT immunolabeling in these structures is attributable to an uptake of 5-HT by the 5-HT plasma membrane transporter. This points to neuron populations that form highly precise projection maps that could be affected by 5-HT during specific developmental stages.
Mots-clé
Animals Brain/embryology/growth & development/*metabolism Carrier Proteins Dopamine/metabolism Dopamine Plasma Membrane Transport Proteins Embryonic and Fetal Development/physiology Membrane Glycoproteins/*metabolism *Membrane Transport Proteins Mice Mice, Inbred CBA Mice, Knockout Monoamine Oxidase/*genetics Nerve Tissue Proteins/*metabolism Neurons/metabolism Norepinephrine/metabolism Norepinephrine Plasma Membrane Transport Proteins Serotonin/*metabolism Serotonin Plasma Membrane Transport Proteins *Symporters
Pubmed
Web of science
Création de la notice
24/01/2008 15:27
Dernière modification de la notice
20/08/2019 16:15
Données d'usage